0000000000199734

AUTHOR

Federico Verzegnassi

showing 3 related works from this author

Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sec…

2021

Summary Background Presenting symptoms of childhood cancers might mimic those of rheumatic diseases. However, the evidence available to guide differential diagnosis remains scarce. Preventing wrong or delayed diagnosis is therefore important to avoid incorrect administration of glucocorticoid or immunosuppressive therapy and worsening of prognosis. As such, we aimed to assess the prevalence and characteristics of presenting musculoskeletal manifestations in patients at cancer onset and to identify the factors that differentiate childhood malignancies with arthropathy from juvenile idiopathic arthritis. Methods We did a multicentre, cross-sectional study at 25 paediatric haemato-oncology cen…

medicine.medical_specialtybusiness.industryImmunologyArthritisCancerOdds ratioMusculoskeletal manifestationJuvenile idiopathic arthritismedicine.diseaseHistiocytosisRheumatologySettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAPrednisoneInternal medicineJoint painArthropathyMusculoskeletal manifestations childhood cancer juvenile idiopathic arthritismedicinechildhood cancerImmunology and AllergyDifferential diagnosismedicine.symptombusinessmedicine.drug
researchProduct

Autoimmune neutropenia of childhood secondary to other autoimmune disorders: Data from the Italian neutropenia registry

2017

0301 basic medicinemedicine.medical_specialtyPediatricsHematologybusiness.industryMEDLINEHematologyNeutropeniamedicine.diseaseInfant newborn03 medical and health sciencesDisease susceptibility030104 developmental biology0302 clinical medicineInternal medicineAutoimmune neutropeniamedicinebusiness030215 immunologyAmerican Journal of Hematology
researchProduct

Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry.

2019

Autoimmune neutropenia of infancy (AIN) is characterized by low risk of severe infection, tendency to spontaneously resolve and typically onset at ≤4-5 years of age; it is due to auto-antibodies whose detection is often difficult. In case of negativity of 4 antineutrophils autoantibody tests, after having excluded ethnic, postinfection, drug induced, or congenital neutropenia, according to the Italian guidelines the patients will be defined as affected by "idiopathic neutropenia" (IN). We describe the characteristics of 85 IN patients enrolled in the Italian neutropenia registry: they were compared with 336 children affected by AIN. The 2 groups were clinically very similar and the main dif…

Malemedicine.medical_specialtyNeutropeniaAutoimmunityNeutropeniaDiagnosis Differential03 medical and health sciences0302 clinical medicineSex FactorsMonocytosisRisk FactorsInternal medicineDiagnosismedicineCongenital Bone Marrow Failure SyndromesHumansRegistriesCongenital NeutropeniaHematologyLeukopeniabusiness.industryAge Factors; Autoimmunity; Congenital Bone Marrow Failure Syndromes; Diagnosis Differential; Female; Humans; Infant; Italy; Leukopenia; Male; Neutropenia; Registries; Risk Factors; Sex FactorsAutoantibodyAge FactorsInfantHematologyLeukopeniamedicine.diseaseSettore MED/38Italy030220 oncology & carcinogenesisAutoimmune neutropeniaDifferentialFemalemedicine.symptomDifferential diagnosisbusiness030215 immunologyAmerican journal of hematology
researchProduct